Joris H. De Maeyer

Turnhout, VLG 2300, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study.

Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study.

Journal: JMIR formative research

Published: July 28, 2022

Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study.

Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study.

Journal: JMIR formative research

Published: July 05, 2021

Selective inhibition of intestinal guanosine 3',5'-cyclic monophosphate signaling by small-molecule protein kinase inhibitors.

Selective inhibition of intestinal guanosine 3',5'-cyclic monophosphate signaling by small-molecule protein kinase inhibitors.

Journal: The Journal of biological chemistry

Published: March 12, 2018

Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist.

Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist.

Journal: The Journal of pharmacology and experimental therapeutics

Published: July 18, 2017

Synergistic effect between 5-HT4 receptor agonist and phosphodiesterase 4-inhibitor in releasing acetylcholine in pig gastric circular muscle in vitro.

Synergistic effect between 5-HT4 receptor agonist and phosphodiesterase 4-inhibitor in releasing acetylcholine in pig gastric circular muscle in vitro.

Journal: European journal of pharmacology

Published: December 23, 2015

Inhibition of Heat-Stable Toxin-Induced Intestinal Salt and Water Secretion by a Novel Class of Guanylyl Cyclase C Inhibitors.

Inhibition of Heat-Stable Toxin-Induced Intestinal Salt and Water Secretion by a Novel Class of Guanylyl Cyclase C Inhibitors.

Journal: The Journal of infectious diseases

Published: February 09, 2015

SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice.

SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice.

Journal: Neuropharmacology

Published: December 09, 2013

Investigation of 5-HT4 receptors in bronchial hyperresponsiveness in cigarette smoke-exposed mice.

Investigation of 5-HT4 receptors in bronchial hyperresponsiveness in cigarette smoke-exposed mice.

Journal: Pulmonary pharmacology & therapeutics

Published: September 03, 2013

Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility.

Cholinergic interactions between donepezil and prucalopride in human colon: potential to treat severe intestinal dysmotility.

Journal: British journal of pharmacology

Published: July 10, 2013

Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor.

Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor.

Journal: EJNMMI research

Published: January 15, 2013

Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice.

Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice.

Journal: Neurobiology of aging

Published: August 31, 2012

Predominant mucosal expression of 5-HT₄(+h) receptor splice variants in pig stomach and colon.

Predominant mucosal expression of 5-HT₄(+h) receptor splice variants in pig stomach and colon.

Journal: World journal of gastroenterology

Published: August 17, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026